mdlinx mdlinx

Pharma News Articles

MDLinx Pharma helps physicians and healthcare professionals stay up to date with the latest pharma news articles and research, as well as pharma jobs, conferences, and resources.

Your Unread Messages in Pharma News

See All >> Messages include industry-sponsored communications and special communications from MDLinx


Latest (14) Full Text Articles (547)
Ranked, sorted, and summarized by MDLinx editors from the latest literature

1 Launch of the Anti-Cancer Agent "Kadcyla" Full Text Chugai Pharmaceutical Co., April 18, 2014

2 Quintiles recognized as industry leader in phase II/III research for second year in a row Full Text Quintiles Transnational, April 18, 2014

3 GSK announces approval in Canada for Incruse Ellipta (umeclidinium) as a treatment for COPD Full Text GlaxoSmithKline, April 18, 2014

4 Liquid chromatography column separates glycans Full Text BioPharm International, April 18, 2014

5 FDA approves Merck’s ragwitek (short ragweed pollen allergen extract) sublingual tablet as immunotherapy to treat short ragweed pollen-induced allergic rhinitis with or without conjunctivitis in adults Full Text Merck, April 18, 2014

6 Teva settles patent litigation with Pfizer on celebrex Full Text Teva Pharmaceutical Industries, April 18, 2014

7 Baxter reports strong first quarter financial results exceeding expectations and confirms 2014 full-year guidance Full Text Baxter, April 18, 2014

8 Amgen announces webcast of 2014 first quarter financial results Full Text Amgen, April 18, 2014

9 Volasertib, Boehringer Ingelheim´s investigational treatment of acute myeloid leukaemia, is granted orphan drug designation in the EU and the US Full Text Boehringer Ingelheim, April 18, 2014

10 GSK and Genmab receive FDA approval for arzerra (ofatumumab) as first-line treatment in combination with chlorambucil for patients with chronic lymphocytic leukemia (CLL) for whom fludarabine-based therapy is considered inappropriate Full Text Genmab, April 18, 2014

11 Aggregation system improves analysis of sub-visible particles Full Text BioPharm International, April 18, 2014

12 Immunogen, inc. announces conference call to discuss its third quarter fiscal year 2014 financial results Full Text ImmunoGen, Inc., April 18, 2014

13 Boston scientific to host and webcast investor event Full Text Boston Scientific, April 18, 2014

14 HBAs women of the year 2014 Full Text Pharmaceutical Executive Magazine, April 18, 2014

Prior Articles

15 Abbvie announces initiation of pivotal phase III study of veliparib (ABT-888) for patients with non-small cell lung cancer Full Text AbbVie, April 17, 2014

16 GSK statement on media reports Full Text GlaxoSmithKline, April 17, 2014

17 Abbott reports first-quarter 2014 results Full Text Abbott, April 17, 2014

18 Baxter meets primary efficacy endpoint in phase 3 trial of BAX 111, investigational stand-alone recombinant treatment for Von Willebrand disease Full Text Baxter, April 17, 2014

19 Mucosis announces a strategic partnership with Changchun BCHT biotechnology of China and raises additional capital Full Text B3C newswire, April 17, 2014

20 Critical pharmaceuticals, the university of Nottingham and Nottingham university hospitals NHS trust starts first phase I clinical trial on a nano-enabled intranasal teriparatide for the treatment of osteoporosis Full Text B3C newswire, April 17, 2014

50 available pages FirstPrevious 1 2 3 4 5 6 7 8 9 10 Next Last

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Pharma Articles

Last month's top read Top Articles of 2013

1 Rentschler announces 3rd industrial cell culture technology conference on processes for virus-based biologics B3C newswire, March 17, 2014    Free full text

2 Treatment for rare metabolic disease approved Drug Topics, March 3, 2014    Free full text

3 GSK and Theravance announce positive results from studies comparing ANORO ELLIPTA with SERETIDE DISKUS and ADVAIR DISKUS in patients with COPD GlaxoSmithKline, March 17, 2014    Free full text

4 FDA details national vaccine plan BioPharm International, March 12, 2014    Free full text

5 Ranbaxy suspends API shipments from two plants in India BioPharm International, February 26, 2014    Free full text

6 First U.S. clinical site opens for CEL-SCIS global phase III immunotherapy head and neck cancer trial expansion CEL-SCI, March 5, 2014    Free full text

7 Biotechnology industry prospects remain strong First Report Managed Care, March 21, 2014    Free full text

8 Merck announces results from phase 2b study of MK-8237, an investigational house dust mite sublingual allergen immunotherapy tablet Merck, March 5, 2014    Free full text

9 Hailey-Hailey disease responding to thalidomide Indian Journal of Dermatology, March 6, 2014    Free full text

10 What do pharmas "High Performers" have in common? Pharmaceutical Executive Magazine, March 10, 2014    Free full text

11 Bristol-Myers Squibb presents promising phase IIb data for novel, investigational attachment inhibitor for HIV-1 infected treatment-experienced patients Bristol Myers-Squibb, March 7, 2014    Free full text

12 Formycon AG: Licensing out of the first biosimilar development project already enables extension of the product pipeline as of 2014 B3C newswire, March 13, 2014    Free full text

13 FDA allows marketing of first medical device to prevent migraine headaches FDA Press Announcements, March 13, 2014    Free full text

14 Sirturo (bedaquiline) receives conditional approval in the European union for the treatment of multi-drug resistant tuberculosis Johnson & Johnson, March 7, 2014    Free full text

15 AAAAI 2014ASTHMA: New phase III data show tiotropium respimat effective across asthma severities Boehringer Ingelheim, March 3, 2014    Free full text

16 Sanofis board of directors propose appointment of Patrick Kron as new independent director Sanofi, March 6, 2014    Free full text

17 Research and publication trends in hospital medicine Journal of Hospital Medicine, March 11, 2014    Evidence Based Medicine

18 Fda approves vibativ for hospitalized patients with bacterial pneumonia FDA Press Announcements, June 25, 2013    Free full text

19 FDA releases guidance on CMC postapproval changes BioPharm International, March 5, 2014    Free full text

20 UPLC system for nano- to microscale separations BioPharm International, March 19, 2014    Free full text

Indexed Journals in Pharma News: U.S.Pharmacist, FDA Drug Alerts, Pharmiwebmore

Other Topics in Pharma News

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register
Upcoming Clinical Trials UPCOMING Clinical Trials

Stay current - Media Tool


Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More